Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900023223Phase 4Not yet recruiting
Phase 4, open-label trial of lidocaine in Post-extubation sore throat (POST) (4 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoints: postoperative sore throat, postoperative hoarseness and 1 more. Planned start Jun 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900023223.